Viewing Study NCT02988960

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2026-02-02 @ 1:48 AM
Study NCT ID: NCT02988960
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-08
First Post: 2016-12-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-small cell lung cancer (NSCLC) View
None Squamous cell carcinoma of the head and neck (SCCHN) View
None Advanced solid tumor View
None Cancer View
None Pancreatic adenocarcinoma View
None Cutaneous melanoma View
None ABBV-927 View
None ABBV-181 View
None Budigalimab View